2 results
Approved WMOCompleted
The primary objective is to demonstrate the safety and feasibility of the STENTYS-BDS.
Approved WMOCompleted
Objectives: A prospective, open label, randomized trial, in which we aim to achieve optimal immunosuppression after renal renal transplantation with maximal reduction of side effects, especially of vascular injury, chronic allograft nephropathy,…